611 computer-programmer-"IMPRS-ML"-"IMPRS-ML"-"IMPRS-ML" positions at Nature Careers in United States
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
-research program with application to diverse groups of childhood catastrophic illness. The position can be filled at the Assistant, Associate or Full faculty level and can be within the Clinician-Scientist
-
profound experience in astronomical space missions to lead internationally visible payload contributions and to carry out a related attractive scientific research program. We expect the professor to attract
-
Employee Assistance Program Family friendly benefits and a variety of employee discounts An array of Employee Social Networks US Annualized Base Salary: Associate Editor: $80,000 / Senior Editor: $95,000
-
The Department of Cardiovascular Medicine and the Cardiovascular Research Center at Mayo Clinic are seeking a physician scientist with a major, translational research program. Experience in early
-
faculty member, the appointee will display accomplishment in developing a nationally or internationally recognized independent research program supported by extramural funding and synergizing with the PNGC
-
expected to be an active participant in advancing this mission by establishing an impactful independent research program supported by extramural funding, developing basic and translational scientific
-
independent research program. NJMS has considerable strengths in biomedical research with ample opportunities for faculty in CDS to collaborate with NIH-funded investigators across a variety of disciplines
-
of computer program changes, updates, rebuilds, and super-user status. Utilizes multi-disciplinary resources to affect optimal schedules and address patient needs in a timely manner. Facilitates the flow of patients
-
-track faculty position at the rank of Associate Professor or Professor. We are seeking candidates with an established, NIH-funded research program in basic cardiovascular science. Experience in
-
to precision oncology clinical trials, we have implemented several innovative NGS-based assays as part of our world-leading clinical genomics program, including MSK-IMPACT for tumor tissue and MSK-ACCESS